Unichem Laboratories soars on getting ANDA approval for Doxazosin tablets

11 Jan 2024 Evaluate

Unichem Laboratories is currently trading at Rs. 466.80, up by 21.30 points or 4.78% from its previous closing of Rs. 445.50 on the BSE.

The scrip opened at Rs. 436.60 and has touched a high and low of Rs. 479.25 and Rs. 436.60 respectively. So far 4642 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 479.25 on 11-Jan-2024 and a 52 week low of Rs. 265.00 on 25-Jan-2023.

Last one week high and low of the scrip stood at Rs. 479.25 and Rs. 436.60 respectively. The current market cap of the company is Rs. 3286.54 crore.

The promoters holding in the company stood at 70.22%, while Institutions and Non-Institutions held 11.31% and 18.47% respectively.

Unichem Laboratories has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC. 

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from Unichem’s Goa Plant. 

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. 

Unichem Lab Share Price

447.15 -6.30 (-1.39%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×